Page last updated: 2024-08-17

medroxyprogesterone acetate and Cystadenoma, Serous

medroxyprogesterone acetate has been researched along with Cystadenoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, Q; Feng, W; Feng, Y; Hua, K; Lu, X; Zhou, X	1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Cystadenoma, Serous

Article	Year
Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. International journal of oncology, 2008, Volume: 33, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Movement; Cystadenoma, Serous; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Progestins; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Time Factors	2008

Article

Year

Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.

International journal of oncology, 2008, Volume: 33, Issue:5

Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Movement; Cystadenoma, Serous; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Progestins; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Time Factors

2008